Search form



CL Mobile Menu

Necrobiosis Lipoidica (Diabeticorum)

Necrobiosis Lipoidica (Diabeticorum)

Necrobiosis Lipoidica (Diabeticorum)Click to enlarge.
Necrobiosis Lipoidica (Diabeticorum)Click to enlarge.

Over several years, brown plaques developed on the legs of a 59-year-old woman with diabetes mellitus and pulmonary sarcoidosis. The plaques were dry and cracked in the winter but otherwise asymptomatic. Physical examination revealed atrophic, red-brown to yellowish plaques with telangiectasia involving both legs.

The differential diagnosis included necrobiosis lipoidica, granuloma annulare, sarcoidosis, lupus erythematosus, and early lipodermatosclerosis.

Key Point: Biopsy revealed a granulomatous infiltrate of epithelioid histiocytes and multinucleated giant cells surrounded by lymphocytes “layered” throughout the dermis. Special stains and polarized microscopy did not reveal any microorganisms or foreign-body material. ANA, anti-dsDNA, and anti-SCL70 were negative. These findings were consistent with necrobiosis lipoidica (diabeticorum).

Treatment: The patient was treated with clobetasol proprionate 0.05% cream. She subsequently underwent bariatric surgery; after significant weight loss, her diabetes improved and no new plaques developed.

Necrobiosis lipoidica (diabeticorum) is a granulomatous dermatitis that affects fewer than 1% of diabetic patients and can rarely affect non-diabetic patients. The skin disease can present before, concurrent with, or after onset of diabetes; the progression of skin disease does not correlate with diabetes control or severity. Plaques are usually painless because of destruction of cutaneous nerves; however, the minority of patients may experience neuropathic pain. Ulceration may follow preceding trauma.

Note: Despite its atrophic surface change, necrobiosis lipoidica is a granulomatous dermatitis that commonly requires super-potent or intralesional corticosteroids for adequate treatment.


Loading comments...

By clicking Accept, you agree to become a member of the UBM Medica Community.